Nystagmus
7
0
0
5
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 7 trials
100.0%
+13.5% vs benchmark
0%
0 trials in Phase 3/4
20%
1 of 5 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 5 completed trials
Clinical Trials (7)
Evaluation of Nystagmus Examination Using Wearable AR Glasses in Vertigo Patients
Alcohol Impairment Detection in Healthy Adult Users With the Gaize Device
Effect of Vestibular Rehabilitation - a Randomized Controlled Trial
Vision in Children Born to Opioid-dependent Methadone-maintained Mothers
Screening for Studies on Nystagmus and Strabismus
Cross-over Comparison of Gabapentin and Memantine as Treatment for Acquired Nystagmus
Eye Muscle Surgery to Treat Congenital Nystagmus